Novel “Inverse Vaccines” Could Soon Target Autoimmune Diseases
A novel class of therapies that are labeled vaccines—known as ‘inverse vaccines’—are designed to treat autoimmune disorders and could be made available in just a few years. In January, Swiss biotech company Anokion—which focuses on improving treatments and health outcomes for individuals suffering with autoimmune disorders—announced promising early human trials of inverse “vaccines” targeting celiac […]